Ritalin and Distractibility - a phase IV clinical study of FDA data

Summary:

Distractibility is found among people who take Ritalin, especially for people who are male, 10-19 old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Ritalin and have Distractibility. It is created by eHealthMe based on reports of 24,248 people who have side effects when taking Ritalin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 18, 2022

24,248 people reported to have side effects when taking Ritalin.
Among them, 23 people (0.09%) have Distractibility.


What is Ritalin?

Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 26,168 Ritalin users for its effectiveness, alternative drugs and more.

What is Distractibility?

Distractibility (inability to sustain one's attention) is found to be associated with 434 drugs and 286 conditions by eHealthMe.

Number of Ritalin and Distractibility reports submitted per year:

Could Ritalin cause Distractibility?

Time on Ritalin when people have Distractibility *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Distractibility when taking Ritalin *:

  • female: 34.78 %
  • male: 65.22 %

Age of people who have Distractibility when taking Ritalin *:

  • 0-1: 0.0 %
  • 2-9: 37.5 %
  • 10-19: 50.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 12.5 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Ritalin *:

  1. Adderall: 2 people, 8.70%
  2. Strattera: 2 people, 8.70%
  3. Provigil: 1 person, 4.35%
  4. Aptensio Xr: 1 person, 4.35%
  5. Cogentin: 1 person, 4.35%
  6. Concerta: 1 person, 4.35%
  7. Depakote: 1 person, 4.35%
  8. Fish Oil: 1 person, 4.35%
  9. Fluoxetine: 1 person, 4.35%
  10. Focalin Xr: 1 person, 4.35%

Common side effects people have besides Distractibility *:

  1. Disturbance In Attention: 7 people, 30.43%
  2. Drug Ineffective: 6 people, 26.09%
  3. Agitation (state of anxiety or nervous excitement): 5 people, 21.74%
  4. Psychomotor Hyperactivity (feelings of extreme restlessness): 4 people, 17.39%
  5. Headache (pain in head): 4 people, 17.39%
  6. Stress And Anxiety: 3 people, 13.04%
  7. Irritability: 3 people, 13.04%
  8. Abnormal Behavior: 3 people, 13.04%
  9. Fatigue (feeling of tiredness): 2 people, 8.70%
  10. Feeling Abnormal: 2 people, 8.70%

Common conditions people have *:

  1. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Ritalin and have Distractibility?

Check whether Distractibility is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Distractibility and when was it recovered:

Expand to all the drugs that have ingredients of methylphenidate hydrochloride:

Alternative drugs to, pros and cons of Ritalin:

Common Ritalin side effects:

Browse all side effects of Ritalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Distractibility treatments and more:

COVID vaccines that are related to Distractibility:

All the drugs that are associated with Distractibility:

Common conditions associated with Distractibility:

All the conditions that are associated with Distractibility:

How the study uses the data?

The study uses data from the FDA. It is based on methylphenidate hydrochloride (the active ingredients of Ritalin) and Ritalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: